Norcantharidin tablets

This product has been tested in vitro on liver cancer BEL-7402 esophageal cancer CaEs-17, laryngeal cancer SMMC-7721, cervical cancer

The main ingredient of this product is norcantharidin, and its chemical name is: exo-1:2-cis-3:6-oxo-hexahydrophthalic anhydride. Molecular formula: C8H8O4 Molecular weight: 168.15

The product is a sugar-coated tablet, which appears white after removing the coating.

Anti-tumor drug. Suitable for patients with liver cancer, esophageal cancer, stomach and cardia cancer, leukopenia, hepatitis, cirrhosis, and hepatitis B virus carriers.

Oral administration. 5-15 mg once, 3 times a day. Start with a small dose and gradually increase the dose. A higher dose can be used for advanced patients, and a reduced dose can be used for children. The course of treatment is one month, and generally 3 courses can be maintained. This product can be used as a preoperative medication or in combined chemotherapy. This product can be used alternately with sodium norcantharidin injection. However, it is not advisable to use the drugs together at the same time.

Some patients may experience symptoms such as nausea, vomiting, and dizziness, which can disappear on their own by stopping the medication, reducing the dosage, or taking symptomatic treatment.

Not yet clear

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: This experiment has not been conducted and there is no reliable reference. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

Not yet clear.

Sealed storage

5mg

Tentative 24 months

Shandong Shanda Kangnuo Pharmaceutical Co., Ltd.

• Founded in:

  2002-09-30

• Address:

  In Shandong University Science and Technology Park, Yingxiu Road, Jinan High-tech Development Zone

• Tax NO.:

  91370100743380534M

• Registered Funds:

  13 million yuan

• Email:

  Log in to view